Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies

BACKGROUND: Disease-modifying therapies are thought to reduce the conversion rate to secondary progressive multiple sclerosis. OBJECTIVE: To explore the rate, chronology, and contributing factors of conversion to the progressive phase in treated relapsing–remitting multiple sclerosis patients. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Coret, Francisco, Pérez-Miralles, Francisco C, Gascón, Francisco, Alcalá, Carmen, Navarré, Arantxa, Bernad, Ana, Boscá, Isabel, Escutia, Matilde, Gil-Perotin, Sara, Casanova, Bonaventura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077906/
https://www.ncbi.nlm.nih.gov/pubmed/30090637
http://dx.doi.org/10.1177/2055217318783347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077906/
https://www.ncbi.nlm.nih.gov/pubmed/30090637
http://dx.doi.org/10.1177/2055217318783347

Ejemplares similares